José Antonio García Erce Highlights the Updating of the Criteria for the Donation of Plasmapheresis for Industrial Fractionation
José Antonio García Erce, Director of the Donation Center, Navarre Health Service (Osasunbidea), posted on LinkedIn:
“NEW CAT 2025 STANDARDS VERSION
As of YESTERDAY, December 19, the 6th edition of the CAT Standards in Hemotherapy 2025 comes into force. From now on, transfusion centres and services will have a period of three months to adopt the changes.
We must congratulate and thank all the professionals involved in the new version. There are interesting new developments.
I would like to highlight the updating of the criteria for the donation of plasmapheresis for industrial fractionation. It can be of great help to Transfusion Centers.
But I want to highlight a point that was already in the previous edition and that should also be applicable to transfusion centers, to Primary Care, as well as to all hospitals where transfusions are made:
4.2.7. TS must promote and participate in hospital Patient Blood Management (PBM) programs, including specific training.
Unfortunately, its definition included in the document, sorry, is not correct: “Patient Blood Management: a comprehensive and multidisciplinary strategy focused primarily on minimizing the use of allogeneic blood components, optimizing patient care by treating anemia, minimizing blood loss and bleeding, and improving their physiological reserve of red blood cells.” It does not focus on minimizing use, but on clinical improvement and patient safety, and preserving, promoting, and protecting the blood health of the entire population.”
Title: Patient blood management: haematology faces an urgent challenge in personalised medicine | Gestión de la sangre del paciente: la hematología ante un reto inaplazable en la medicina personalizada (original)
Authors: José Antonio García Erce
Read full paper here or have printable variant.
Read more from José Antonio García Erce on Hemostasis Today.
-
Feb 25, 2026, 09:14Nominations are Open for 2027 Committee and Leadership Positions – ASH
-
Feb 25, 2026, 09:08Bastu Odoka: Closing the Gap on Anti-D Prophylaxis in Maternal Care
-
Feb 25, 2026, 08:53Eiman Alzaabi: Sharing Rare Observations and Challenging Assumptions in Transfusion Medicine
-
Feb 25, 2026, 08:40Matthew Flick։ A Great Gordon Research Conference on Plasminogen Activation and Extracellular Proteolysis
-
Feb 24, 2026, 16:18Salmaan Dalvi: Mapping Rare Diseases Across East and Central Africa
-
Feb 24, 2026, 16:16Wolfgang Miesbach: Game‑Changing Data on Intensive FVIII Replacement in Haemophilia A with Hypertrophic Synovium
-
Feb 24, 2026, 16:01Is It Safe to Briefly Stop Anticoagulation After VTE? – RPTH Journal
-
Feb 24, 2026, 15:58Anastasia Conti: Honored to Receive the Roche Foundation Grant for Independent Research in Onco-Hematology
-
Feb 24, 2026, 15:55Courtney Lawrence: Targeted Donor Screening Reduces Transfusion-Transmitted Babesia Cases